Guidelines for Nitrous Oxide Use in Labor and Delivery

Maternal Safety Profile

Dizziness is the most common maternal side effect, occurring in approximately 39 % of parturients receiving nitrous oxide. British Thoracic Society (BTS) Grade D evidence. 1
The self‑administration mechanism enhances safety: if a patient experiences excessive drowsiness, she can simply release the mask and breathe ambient air, terminating exposure. BTS evidence. 1
Pulse‑oximetry monitoring during nitrous‑oxide administration is recommended as best practice to detect hypoxemia promptly. BTS evidence. 1

Hypercapnic respiratory failure risk (e.g., severe COPD, emphysema, or any chronic respiratory disease) is an absolute contraindication; BTS assigns a Grade D recommendation. 1
Severe maternal respiratory compromise or hypoxemia precludes nitrous‑oxide use because of the danger of rapid hypercapnia/hypoxemia swings. BTS evidence. 1
Opioid‑dependent women receiving medication‑assisted treatment (MAT) (e.g., methadone or buprenorphine) should avoid nitrous oxide because it provides less analgesia and increases sedation risk; early neuraxial analgesia is advised. American College of Obstetricians and Gynecologists (ACOG) guidance. [4][5]
Use of opioid agonist‑antagonists (e.g., nalbuphine, butorphanol) is contraindicated after nitrous‑oxide exposure or concurrent opioid use, as they may precipitate withdrawal. ACOG guidance. [4][5]
During the COVID‑19 pandemic, nitrous‑oxide delivery should be avoided because the device can generate aerosolized particles, increasing infection risk. Anaesthesia guidance (2020). 7

Deliver a 50 % nitrous‑oxide / 50 % oxygen mixture (Entonox) via a self‑administered demand valve. BTS protocol. 1
Instruct the patient to begin inhalation at the onset of each uterine contraction; analgesic effect occurs within a few breaths. BTS protocol. 1
Continuous pulse‑oximetry should be employed throughout use to ensure adequate oxygenation. BTS protocol. 1

Nitrous‑oxide is rapidly cleared by exhalation; no waiting period is required before breastfeeding after maternal exposure. Anaesthesia evidence (2020). 3

Neuraxial analgesia (epidural or combined spinal‑epidural) remains the gold‑standard for labor pain, offering superior analgesia and is strongly recommended, especially for opioid‑dependent parturients. ACOG and American Society of Anesthesiologists (ASA) guidance. [4][5]8
Patient‑controlled epidural analgesia (PCEA) provides flexible dosing with reduced overall drug consumption compared with continuous infusion. ASA evidence (2007). 8
For cesarean delivery, neuraxial anesthesia (spinal or epidural) is strongly preferred over general anesthesia, reinforcing the superiority of regional techniques. Anaesthesia guidance (2020). 7

Recommendation	Evidence Strength / Society
Avoid nitrous oxide in patients with hypercapnic respiratory risk, severe hypoxemia, or COPD/emphysema.	BTS Grade D
Do not use nitrous oxide in opioid‑dependent women on MAT; offer early neuraxial analgesia.	ACOG
Employ continuous pulse‑oximetry during nitrous‑oxide administration.	BTS
Use 50/50 nitrous‑oxide / oxygen via demand valve; instruct inhalation at contraction onset.	BTS
No breastfeeding delay required after nitrous‑oxide use.	Anaesthesia (2020)
Avoid nitrous‑oxide delivery during COVID‑19 pandemic due to aerosolization risk.	Anaesthesia (2020)
Prefer neuraxial analgesia (epidural/combined spinal‑epidural) as first‑line labor pain control; especially for opioid‑dependent patients.	ACOG, ASA
Use PCEA for flexible epidural dosing with reduced drug load.	ASA (2007)
For cesarean sections, choose neuraxial over general anesthesia.	Anaesthesia (2020)